Philip Scheltens is Partner and Head of the Dementia Fund in the EQT Life Sciences team. Philip was Managing Partner at LSP from 2021 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences. previously called LSP (Life Sciences Partners).
Prior to joining LSP, Philip worked as a Director of the Alzheimer Center at Amsterdam University Medical Center in Amsterdam, The Netherlands.
Philip is an MD (neurology) and holds a PhD in Medicine from the VU University Amsterdam and is Professor of Neurology at the Amsterdam University Medical Center.